SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): DECEMBER 27, 1999
PHARMACEUTICAL FORMULATIONS, INC.
(Exact Name of Registrant as Specified in Charter)
DELAWARE 0-11274 22-2367644
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
460 PLAINFIELD AVENUE, EDISON, NEW JERSEY 08818
(Address of Principal Executive Offices, including Zip Code)
Registrant's telephone number, including area code: 732-985-7100
N.A.
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
ITEM 5. OTHER EVENTS
The Company reported on December 27, 1999 that Charles LaRosa will
retire as President and Chief Executive Officer of the Company on December 31,
1999. Mr. LaRosa will remain a member of the Company's Board of Directors. A
replacement for Mr. LaRosa has not been announced.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PHARMACEUTICAL FORMULATIONS, INC.
By: /s/ CLIFFORD H. STRAUB, JR.
----------------------------------
Name: Clifford H. Straub, Jr.
Title: Senior Vice President-Chief
Administrative Officer; Chief
Financial Officer
Dated: December 29, 1999
